全文获取类型
收费全文 | 22870篇 |
免费 | 1196篇 |
国内免费 | 254篇 |
专业分类
耳鼻咽喉 | 252篇 |
儿科学 | 479篇 |
妇产科学 | 667篇 |
基础医学 | 2603篇 |
口腔科学 | 522篇 |
临床医学 | 1683篇 |
内科学 | 6157篇 |
皮肤病学 | 397篇 |
神经病学 | 2473篇 |
特种医学 | 889篇 |
外科学 | 3635篇 |
综合类 | 45篇 |
一般理论 | 4篇 |
预防医学 | 903篇 |
眼科学 | 281篇 |
药学 | 1350篇 |
中国医学 | 48篇 |
肿瘤学 | 1932篇 |
出版年
2024年 | 23篇 |
2023年 | 184篇 |
2022年 | 398篇 |
2021年 | 710篇 |
2020年 | 441篇 |
2019年 | 523篇 |
2018年 | 685篇 |
2017年 | 556篇 |
2016年 | 639篇 |
2015年 | 714篇 |
2014年 | 927篇 |
2013年 | 1119篇 |
2012年 | 1766篇 |
2011年 | 1791篇 |
2010年 | 1011篇 |
2009年 | 994篇 |
2008年 | 1618篇 |
2007年 | 1598篇 |
2006年 | 1454篇 |
2005年 | 1382篇 |
2004年 | 1350篇 |
2003年 | 1211篇 |
2002年 | 1072篇 |
2001年 | 151篇 |
2000年 | 118篇 |
1999年 | 163篇 |
1998年 | 184篇 |
1997年 | 165篇 |
1996年 | 166篇 |
1995年 | 126篇 |
1994年 | 85篇 |
1993年 | 95篇 |
1992年 | 91篇 |
1991年 | 68篇 |
1990年 | 63篇 |
1989年 | 77篇 |
1988年 | 50篇 |
1987年 | 64篇 |
1986年 | 52篇 |
1985年 | 37篇 |
1984年 | 55篇 |
1983年 | 48篇 |
1982年 | 35篇 |
1981年 | 41篇 |
1980年 | 42篇 |
1979年 | 19篇 |
1978年 | 14篇 |
1977年 | 20篇 |
1976年 | 14篇 |
1974年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
Andrea Chiricozzi Nicola Pimpinelli Federica Ricceri Giovanni Bagnoni Laura Bartoli Mauro Bellini Luca Brandini Marzia Caproni Antonio Castelli Michele Fimiani Franco Marsili Carlo Mazzatenta Maria Chiara Niccoli Salvatore Panduri Michele Pellegrino Riccardo Sirna Walter Volpi Marco Romanelli Francesca Prignano 《Dermatologic therapy》2017,30(6)
Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythematous and scaly plaques. Treatment approach is mainly driven by disease severity, though several factors should be considered in order to identify the optimal therapeutic choice. Mild psoriasis may be treated with a wide array of topical agents including corticosteroids, vitamin D analogs, keratolytics, and calcipotriol/betamethasone propionate compound. Because guidelines may not provide practical indications regarding the therapeutic approach, the use of topical agents in psoriasis is more individually tailored. In order to homogenize the standard of care, at least in a local setting, we collected the real‐life‐based recommendations for the use of topical therapies from an expert panel, the Tuscany Consensus Group on Psoriasis, representing all leading centers for psoriasis established in Tuscany. With this document, this consensus group sought to define principles guiding the selection of therapeutic agents with straightforward recommendations derived from a real‐life setting. 相似文献
972.
Pierri Vincenzo Dagostino Sabino Vasta Rosario Ercoli Tommaso Piga Giuseppe Melas Valerio Bruder Francesca Conti Carlo Cappai Pier Francesco Manieli Cristina Melis Maurizio Floris Gianluca Melis Marta Muroni Antonella Maleci Alberto Defazio Giovanni 《Neurological sciences》2022,43(1):419-425
Neurological Sciences - To study for the first time the incidence of adult-onset CNS tumors in Southern Sardinia, Italy. Clinical records of patients > 18 years old who... 相似文献
973.
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs 总被引:12,自引:0,他引:12
Fiorucci S Antonelli E Distrutti E Rizzo G Mencarelli A Orlandi S Zanardo R Renga B Di Sante M Morelli A Cirino G Wallace JL 《Gastroenterology》2005,129(4):1210-1224
BACKGROUND & AIMS: Hydrogen sulfide (H(2)S), an endogenous gaseous mediator that causes vasodilation, is generated in mammalian tissues by cystathionine beta-synthase (CBS) and cystathionine-gamma-lyase (CSE). Here, we have investigated the role of H(2)S in a rodent model of nonsteroidal anti-inflammatory drug (NSAID) gastropathy. METHODS: Rats were given acetyl salycilic acid (ASA) or an NSAID alone or in combination with NaHS, an H(2)S donor, and killed 3 hours later. Gastric blood flow was measured by laser-Doppler flowmetry, whereas intravital microscopy was used to quantify adhesion of leukocytes to mesenteric postcapillary endothelium. RESULTS: At a dose of 100 micromol/kg, NaHS attenuated by 60%-70% the gastric mucosal injury, and tumor necrosis factor (TNF)-alpha, intercellular adhesion molecule (ICAM)-1, and lymphocyte function-associated antigen (LFA)-1 mRNA up-regulation induced by NSAIDs (P < .05) NaHS administration prevented the associated reduction of gastric mucosal blood flow (P < .05) and reduced ASA-induced leukocyte adherence in mesenteric venules. NaHS did not affect suppression of prostaglandin E(2) (PGE(2)) synthesis by NSAIDs. Glibenclamide, a K(ATP) channel inhibitor, and DL-propargylglycine, a CSE inhibitor, exacerbated, whereas pinacidil, a K(ATP) opener, attenuated gastric injury caused by ASA. Exposure to NSAIDs reduced H(2)S formation and CSE expression (mRNA and protein) and activity by 60%-70%. By promoter deletion and mutation analysis, an Sp1 consensus site was identified in the CSE promoter. Exposure to NSAIDs inhibits Sp1 binding to its promoter and abrogates CSE expression in HEK-293 cells transfected with a vector containing the core CSE promoter. Exposure to NSAIDs inhibits Sp1 and ERK phosphorylation. CONCLUSIONS: These data establish a physiologic role for H(2)S in regulating the gastric microcirculation and identify CSE as a novel target for ASA/NSAIDs. 相似文献
974.
It has been recently shown that in vitro platelet aggregation is inhibited when platelet concentration in platelet-rich plasma (PRP) is “normalized” by the addition of platelet-poor plasma (PPP). In this study we tested the hypothesis that the large amount of PPP required to “normalize” PRP in patients with thrombocytosis may result in falsely defective platelet function. To this end, we evaluated platelet aggregation in PRP samples “normalized” with either PPP or buffer in 16 patients with high platelet counts induced by myeloproliferative disorders. Comparison with the results obtained in healthy subjects demonstrated that patients had reduced platelet responses to ADP or collagen in PRP/PPP samples, but normal responses in PRP/buffer. By contrast, the majority of patients had severely defective platelet response to epinephrine independently from the methodological approach. We suggest that the reduced in vitro platelet aggregation previously described in patients with myeloproliferative disorders and thrombocytosis partially derived from a laboratory artefact. 相似文献
975.
Although the evolutionary theories of aging are quite well established, our knowledge about how we age is still very limited. The abundance and heterogeneity of available mechanistic theories of aging implicitly suggest that this phenomenon is overly complex and unlikely to be explained by a single pathway. Moreover, although aging remains a unique process, it is characterized by heterogeneous manifestations, not only determining inter-individual variations, but even intra-individual diversities. Such heterogeneity renders the inner nature of the aging process of difficult evaluation in older persons due to the potential biases introduced by multiple age-related social, biological, and clinical factors (and responsible for the evidence-based issue in geriatrics). Moving from the difficulties in translating anti-aging preclinical interventions into clinical trials, an alternative approach is illustrated. We encourage moving to a holistic evaluation of aging by adopting specific and consequent modifications in the design and conduction of clinical research. Such approach is today commonly applied in the clinical setting where the complexity of older patients often requires multidimensional interventions to adequately target the geriatric syndromes. Consistently, interventions targeting the aging process may result ineffective if too focused on a single underlying causal mechanism and/or failing to capture the complexity of the phenomenon. In this context, frailty (a geriatric syndrome characterized by age-related declines occurring across multiple physiologic systems) may indeed represent a clinically relevant threshold throughout the continuum of the aging process and a promising benchmark to test multidomain interventions against age-related conditions. 相似文献
976.
977.
Prevalence,severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes 下载免费PDF全文
Fabio Efficace Gianluca Gaidano Massimo Breccia Marianna Criscuolo Francesco Cottone Giovanni Caocci David Bowen Michael Lübbert Emanuele Angelucci Reinhard Stauder Dominik Selleslag Uwe Platzbecker Grazia Sanpaolo Anna Jonasova Francesco Buccisano Giorgina Specchia Giuseppe A. Palumbo Pasquale Niscola Chonghua Wan Huiyong Zhang Susanna Fenu Virginia Klimek Odile Beyne‐Rauzy Khanh Nguyen Franco Mandelli 《British journal of haematology》2015,168(3):361-370
The primary objective of this study was to investigate factors associated with fatigue severity in newly diagnosed patients with higher‐risk myelodysplastic syndromes (MDS). The secondary objectives were to assess symptom prevalence and to examine the relationships between fatigue, quality of life (QoL) and overall symptom burden in these patients. The analyses were conducted in 280 higher‐risk MDS patients. Pre‐treatment patient‐reported fatigue was evaluated with the Functional Assessment of Chronic Illness Therapy (FACIT)‐Fatigue scale and QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30 (EORTC QLQ‐C30). Female gender (P = 0·018), poor performance status (i.e., ECOG of 2–4) (P < 0·001) and lower levels of haemoglobin (Hb) (P = 0·026) were independently associated with higher fatigue severity. The three most prevalent symptoms were as follows: fatigue (92%), dyspnoea (63%) and pain (55%). Patients with higher levels of fatigue also had greater overall symptom burdens. The mean global QoL scores of patients with the highest versus those with the lowest levels of fatigue were 29·2 [standard deviation (SD), 18·3] and 69·0 (SD, 18·8), respectively and this difference was four times the magnitude of a clinically meaningful difference. Patient‐reported fatigue severity revealed the effects of disease burden on overall QoL more accurately than did degree of anaemia. Special attention should be given to the female patients in the management of fatigue. 相似文献
978.
979.
Guercio Giovanni Cudia Bianca Ricotta Calogero Bavetta Francesco Diana Giuseppe 《BMC geriatrics》2009,9(1):1-4
Falls remain a major public health problem, despite strong growth in the research evidence of effective single and multifactorial interventions, particularly in the community setting. A number of aspects of falls prevention require individual tailoring, despite limitations being reported regarding some of these, including questions being raised regarding the role of falls risk screening and falls risk assessment. Being able to personalise an individual's specific risk and risk factors, increase their understanding of what interventions are likely to be effective, and exploring options of choice and preference, can all impact upon whether or not an individual undertakes and sustains participation in one or more recommendations, which will ultimately influence outcomes. On all of these fronts, the individual patient receiving appropriate and targeted interventions that are meaningful, feasible and that they are motivated to implement, remains central to effective translation of falls prevention research evidence into practice. 相似文献
980.
Jennifer M. Kalish Leslie G. Biesecker Frederic Brioude Matthew A. Deardorff Alessandra Di Cesare‐Merlone Todd Druley Giovanni B. Ferrero Pablo Lapunzina Lidia Larizza Saskia Maas Marina Macchiaiolo Eamonn R. Maher Silvia Maitz Julian A. Martinez‐Agosto Alessandro Mussa Peter Robinson Silvia Russo Angelo Selicorni Raoul C. Hennekam 《American journal of medical genetics. Part A》2017,173(7):1735-1738